US Stock MarketDetailed Quotes

PTVE Pactiv Evergreen

Watchlist

17.900
+0.020+0.11%

Close Mar 18 16:00 ET

17.950
+0.050+0.28%

Pre 06:08 ET

3.23BMarket Cap-23.25P/E (TTM)

Pactiv Evergreen Stock Forum

Moomoo AI

Jan 16, 2024 23:50

Despite the current undervaluation of PTVE, the negative growth outlook introduces a level of uncertainty and risk. Potential investors are advised to research further into the stock and consider the risks associated with negative future growth prospects.

Is Now The Time To Look At Buying Pactiv Evergreen Inc. (NASDAQ:PTVE)?

Moomoo AI

Dec 21, 2023 01:00

The pessimism of the analyst cohort reflected in Pactiv Evergreen's declining revenue forecasts might impact its stocks. The current high P/S may not be sustainable due to these decreasing revenues.

Risks To Shareholder Returns Are Elevated At These Prices For Pactiv Evergreen Inc. (NASDAQ:PTVE)

Moomoo AI

Nov 24, 2023 18:39

Although Pactiv Evergreen's dividends were covered by free cash flow, its lack of profitability last year is worrisome. Dividend investors need to see evidence of sustained profitability to be positive.

Income Investors Should Know That Pactiv Evergreen Inc. (NASDAQ:PTVE) Goes Ex-Dividend Soon

Moomoo Breakfast US

Jun 1, 2022 20:21

Columns Today's pre-market stock movers: CRM, WB, LI, NIO and more

Gainers:
• $Victoria's Secret (VSCO.US)$ +10.4% (In reaction to earnings)
• $Salesforce (CRM.US)$ +9.0% (In reaction to earnings)
• $Navigator (NVGS.US)$ +4.9% (names Mads Peter Zacho as CEO)
• $Weibo (WB.US)$ +4.7% (In reaction to earnings)
• $CAE Inc (CAE.US)$ +4.7% (In reaction to earnings)
• $Laredo Petroleum (LPI.US)$ +4% (authorized $200 mln share repurchase program)
• $Axsome Therapeutics (AXSM.US)$ +3.1% (Late-Breaking Presentations of P...

Moomoo Breakfast US

May 23, 2022 20:11

Columns Today's pre-market stock movers: BNTX, JPM, RIVN, HPQ and more

Gainers:
• $Genco Shipping & Trading (GNK.US)$ +4.7% (positive Barrons article)
• $NextDecade (NEXT.US)$ +4.7% (files for 4618226 share common stock offering by selling shareholder)
• $COMPASS Pathways (CMPS.US)$ +4.7% (COMPASS Pathways presents largest ever study of psilocybin therapy at American Psychiatric Association annual meeting)
• $Canoo (GOEV.US)$ +3.5% (files for 48043111 share common stock offering by selling shareholder)
• $American Axle & Mfg (AXL.US)$ +3.7% (pr...

Analysts Notebook

May 23, 2022 19:15

Columns Top upgrades and downgrades on 5/23

Upgrades
• $CubeSmart (CUBE.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $52 (from $60)
• $DTE Energy (DTE.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $140 (from $142)
• $Consolidated Edison (ED.US)$ : Guggenheim Upgrades to Neutral from Sell - PT $94 (from $80)
• $Motorola Solutions (MSI.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $240
• $Central North Airport (OMAB.US)$ : Morgan Stanley Upgrades to...

Analysts Notebook

May 6, 2022 18:44

Columns Top upgrades and downgrades on 5/6

Upgrades
• $Boot Barn Holdings (BOOT.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $121 (from $109)
• $EPAM Systems (EPAM.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $400 (from $312)
• $Hersha Hospitality Trust (HT.US)$ : Stifel Upgrades to Buy from Hold - PT $14.50 (from $11)
• $Jounce Therapeutics (JNCE.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $20 (from $15)
• $Pactiv Evergreen (PTVE.US)$ : RBC Capital Upgra...

Analysts Notebook

Apr 14, 2022 19:26

Columns Top upgrades and downgrades on 4/14

Upgrades
• $CDW Corp (CDW.US)$: Stifel Upgrades to Buy from Hold - PT $210 (from $200)
• $Corteva (CTVA.US)$ : Loop Capital Upgrades to Buy from Hold - PT $69
• $CoreCivic, Inc. (CXW.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $17 (from $10.85)
• $Delta Air Lines (DAL.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $60 (from $42)
• $H.B. Fuller (FUL.US)$ : Baird Upgrades to Outperform from Neutral - PT $85
• $Huntington Ingalls Industries (HII.US)$ : Cowen U...